BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1268091)

  • 21. The 125I-fibrinogen euglobulin clot-lysis test.
    Horvath AE; Gralnick HR
    Am J Clin Pathol; 1978 Aug; 70(2):271-4. PubMed ID: 696685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinogen turnover in pregnant rabbits during the first and last thirds of gestation.
    Müller-Berghaus G; Moeller RM; Mahn I
    Am J Obstet Gynecol; 1978 Jul; 131(6):655-60. PubMed ID: 99036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continued incorporation of circulating radiolabeled fibrinogen into preformed coronary artery thrombi.
    Salimi A; Oliver GC; Lee J; Sherman LA
    Circulation; 1977 Aug; 56(2):213-7. PubMed ID: 872312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics, tissue distribution and excretion of porcine fibrinogen after intraperitoneal injection of a porcine-derived fibrin glue to rats.
    Xie Y; Zhong G; He H; Fan G; Wu Y
    J Pharm Biomed Anal; 2011 Jan; 54(1):148-53. PubMed ID: 20828964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase by adrenaline or angiotensin II of the accumulation of low density lipoprotein and fibrinogen by aortic walls in unrestrained conscious rats.
    Cardona-Sanclemente LE; Born GV
    Br J Pharmacol; 1996 Mar; 117(6):1089-94. PubMed ID: 8882601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibronectin: blood turnover in normal animals and during intravascular coagulation.
    Sherman LA; Lee J
    Blood; 1982 Sep; 60(3):558-63. PubMed ID: 7104486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble fibrin monomer complexes and fibrinolytic activity in kidney during the generalized Shwartzman reaction in rabbit.
    Szczepanski M; Lucer C
    Thromb Res; 1975 May; 6(5):399-408. PubMed ID: 1135791
    [No Abstract]   [Full Text] [Related]  

  • 28. The course and prerequisites of Lys-plasminogen formation during fibrinolysis.
    Suenson E; Thorsen S
    Biochemistry; 1988 Apr; 27(7):2435-43. PubMed ID: 3382632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The fate of soluble fibrin monomer in relation to intravascular fibrin formation and degradation in rabbits.
    Gurewich V; Wetmore R; Nowak A; Lipinski B
    Blood; 1974 Nov; 44(5):723-33. PubMed ID: 4420440
    [No Abstract]   [Full Text] [Related]  

  • 30. [In vivo and in vitro degradation of fibrin adhesives (studies in rats)].
    Pflüger H; Redl H
    Z Urol Nephrol; 1982 Jan; 75(1):25-30. PubMed ID: 6175121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinogen and fibrinogen/fibrin degradation products in the urine of rabbits infected with Trypanosoma (trypanozoon) brucei.
    Boreham PF; Facer CA
    Z Parasitenkd; 1977 Jul; 52(3):257-65. PubMed ID: 906631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombus-related uptake and vascular clearance of 131 I-fibrin des-AABB as compared to 125 I-fibrinogen in patients with established venous thrombosis.
    Nilsen DW; Brosstad F; Holm B; Kierulf P; Gravem K; Godal HC
    Thromb Haemost; 1984 Apr; 51(2):165-8. PubMed ID: 6740548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding properties of monoclonal antibodies against human fragment D-dimer of cross-linked fibrin to human plasma clots in an in vivo model in rabbits.
    Holvoet P; Stassen JM; Hashimoto Y; Spriggs D; Devos P; Collen D
    Thromb Haemost; 1989 Apr; 61(2):307-13. PubMed ID: 2749602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative assessment of soluble fibrin in plasma by affinity chromatography--a comparative study with desAA-fibrin, desAABB-fibrin and fibrinogen.
    Thiel W; Delvos U; Müller-Berghaus G
    Thromb Haemost; 1985 Aug; 54(2):533-8. PubMed ID: 4082091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 36. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma.
    Soe G; Kohno I; Inuzuka K; Itoh Y; Matsuda M
    Blood; 1996 Sep; 88(6):2109-17. PubMed ID: 8822930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Affects of hirudin and heparin on the binding of new fibrin to the thrombus in t-PA treated rabbits.
    Agnelli G; Pascucci C; Cosmi B; Nenci GG
    Thromb Haemost; 1991 Nov; 66(5):592-7. PubMed ID: 1839474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase.
    Collen D; Van Hoef B; Schlott B; Hartmann M; Gührs KH; Lijnen HR
    Eur J Biochem; 1993 Aug; 216(1):307-14. PubMed ID: 7689966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinogen, fibrin and crosslinking in aging arterial thrombi.
    McBane RD; Ford MA; Karnicki K; Stewart M; Owen WG
    Thromb Haemost; 2000 Jul; 84(1):83-7. PubMed ID: 10928475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incorporation of 125 I-fibrinogen in circulating soluble fibrin monomer complexes during hypercoagulability.
    von Hugo R; Hafter R; Stein B; Stemberger A; Rjosk H; Graeff H
    Thromb Res; 1977 May; 10(5):703-10. PubMed ID: 329464
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.